These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1657238)

  • 61. Relationship of high tissue concentrations of azithromycin to bactericidal activity and efficacy in vivo.
    Retsema JA; Girard AE; Girard D; Milisen WB
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():83-9. PubMed ID: 2154442
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Azithromycin in lower respiratory tract infections.
    Lode H; Schaberg T
    Scand J Infect Dis Suppl; 1992; 83():26-33. PubMed ID: 1336893
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Studies on the intravenous pharmacokinetics in rabbit and in vitro protein binding of two new salts of erythromycin: erythromycin maltobionate and erythromycin fumarate.
    Basu SK; Manna PK; Goswami BB
    Biopharm Drug Dispos; 1992 Aug; 13(6):437-43. PubMed ID: 1391680
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Counihan M; Graf JA; Durol AL; Mertzanis P; Duan SX; Wright CE; Shader RI
    Clin Pharmacol Ther; 1998 Sep; 64(3):278-85. PubMed ID: 9757151
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Pharmacokinetics of deflazacort in rabbits after intravenous and oral administration and its interaction with erythromycin.
    Escudero AI; Marín P; Cárceles CM; Escudero E
    J Vet Pharmacol Ther; 2018 Feb; 41(1):e10-e15. PubMed ID: 28741668
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics of azithromycin and erythromycin in human endometrial epithelial cells and in cells infected with Chlamydia trachomatis.
    Raulston JE
    J Antimicrob Chemother; 1994 Nov; 34(5):765-76. PubMed ID: 7706172
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Tissue distribution of dirithromycin: comparison with erythromycin.
    Bergogne-Bérézin E
    J Antimicrob Chemother; 1993 Mar; 31 Suppl C():77-87. PubMed ID: 8478314
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Single oral dose pharmacokinetics of erythromycin and roxithromycin and the effects of chronic dosing.
    Birkett DJ; Robson RA; Grgurinovich N; Tonkin A
    Ther Drug Monit; 1990 Jan; 12(1):65-71. PubMed ID: 2305423
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative pharmacokinetics of macrolides.
    Nilsen OG
    J Antimicrob Chemother; 1987 Nov; 20 Suppl B():81-8. PubMed ID: 3323170
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection.
    Gladue RP; Bright GM; Isaacson RE; Newborg MF
    Antimicrob Agents Chemother; 1989 Mar; 33(3):277-82. PubMed ID: 2543276
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Serum and tissue concentrations of erythromycin in calves with induced pneumonic pasteurellosis.
    Burrows GE; Gentry M; Ewing P
    Am J Vet Res; 1989 Jul; 50(7):1166-9. PubMed ID: 2774339
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Efficacy of azithromycin for therapy of active syphilis in the rabbit model.
    Lukehart SA; Fohn MJ; Baker-Zander SA
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():91-9. PubMed ID: 2154443
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of the acid stability of azithromycin and erythromycin A.
    Fiese EF; Steffen SH
    J Antimicrob Chemother; 1990 Jan; 25 Suppl A():39-47. PubMed ID: 2154437
    [TBL] [Abstract][Full Text] [Related]  

  • 74. In vivo activity of the macrolide antibiotics azithromycin, roxithromycin and spiramycin against Toxoplasma gondii.
    Araujo FG; Shepard RM; Remington JS
    Eur J Clin Microbiol Infect Dis; 1991 Jun; 10(6):519-24. PubMed ID: 1655433
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Absolute bioavailability of clarithromycin after oral administration in humans.
    Chu SY; Deaton R; Cavanaugh J
    Antimicrob Agents Chemother; 1992 May; 36(5):1147-50. PubMed ID: 1387301
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Randomised controlled trial of single-dose azithromycin in treatment of trachoma.
    Bailey RL; Arullendran P; Whittle HC; Mabey DC
    Lancet; 1993 Aug; 342(8869):453-6. PubMed ID: 8102427
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vivo evaluation of three acid-stable azalide compounds, L-701,677, L-708,299 and L-708,365 compared to erythromycin, azithromycin and clarithromycin.
    Gill CJ; Abruzzo GK; Flattery AM; Smith JG; Jackson J; Kong L; Wilkening R; Shankaran K; Kropp H; Bartizal K
    J Antibiot (Tokyo); 1995 Oct; 48(10):1141-7. PubMed ID: 7490222
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human pharmacokinetics of erythromycin propionate-N-acetylcysteinate: comparative evaluation with erythromycin stearate and N-acetylcysteine.
    De Bernardi M; Feletti F; Gazzani G; Fregnan GB
    Int J Clin Pharmacol Ther Toxicol; 1988 Sep; 26(9):444-7. PubMed ID: 3198299
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preferential concentration of azithromycin in an infected mouse thigh model.
    Retsema JA; Bergeron JM; Girard D; Milisen WB; Girard AE
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():5-16. PubMed ID: 8396096
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Azithromycin, erythromycin and cloxacillin in the treatment of infections of skin and associated soft tissues. European Azithromycin Study Group.
    Daniel R
    J Int Med Res; 1991; 19(6):433-45. PubMed ID: 1663466
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.